Elevated ROS levels can suppress HIF-1α degradation, finally leading to an increased VEGF expression and subsequent angiogenesis in distinct cancer types such as prostate and ovarian cancer and fibrosarcoma [116,156]. The gene discussed is VEGFA; the disease is cancer.